Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

  • A. Michael Lincoff

Part of the Contemporary Cardiology book series (CONCARD)

Table of contents

  1. Front Matter
    Pages i-x
  2. Basic Principles

    1. Front Matter
      Pages 1-1
    2. Thaddeus R. Tolleson, Robert A. Harrington
      Pages 3-21
    3. Edward E. Plow
      Pages 23-37
    4. Barry S. Coller
      Pages 73-101
  3. Glycoprotein IIb/IIIa Blockade During Coronary Intervention

    1. Front Matter
      Pages 103-103
    2. A. Michael Lincoff
      Pages 105-124
    3. Jean-Pierre Deg, J. Conor O’Shea, James E. Tcheng
      Pages 125-146
    4. Nicholas Valettas, Howard C. Herrmann
      Pages 147-166
    5. A. Michael Lincoff, Eric J. Topol
      Pages 167-199
  4. Glycoprotein IIB/IIIA Blockade for Acute Ischemic Syndromes

    1. Front Matter
      Pages 201-201
    2. Marcel J. B. M. van den Brand, Maarten L. Simoons
      Pages 203-231
    3. David J. Moliterno
      Pages 233-262
  5. Practical Issues and Future Applications

    1. Front Matter
      Pages 303-303
    2. Daniel B. Mark
      Pages 305-319
    3. Amol S. Bapat, Naji Yazbek, Neal S. Kleiman
      Pages 341-364
    4. L. Kristin Newby
      Pages 365-382
    5. Dean J. Kereiakes, Pascal J. Goldschmidt-Clermont
      Pages 383-396
    6. Leslie Cho, Jay S. Yadav
      Pages 397-407
    7. David E. Kandzari, David F. Kong, Robert M. Califf
      Pages 425-458
  6. Back Matter
    Pages 459-476

About this book


A. Michael Lincoff takes advantage of critically important new knowledge arising from recent clinical trials to update and expand his acclaimed Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. This substantially enhanced Second Edition contains new chapters on the role of GPIIb/IIIa blockade during acute coronary syndromes, on outcomes with chronic oral GPIIb/IIIa blockade following acute coronary syndromes, and on fibrinolytic therapy during acute myocardial infarctions. Additional enhancements include revised findings from the latest trials of GPIIb/IIIa inhibition during percutaneous coronary intervention, discussion of GPIIb/IIIa blockade with other platelet and thrombin inhibitors, and a review of the potential effects beyond inhibition of platelet aggregation. The book also explains the scientific basis of this therapy, evaluates its benefits and risks for patients, and summarizes detailed data from its various clinical trials.
Comprehensive and definitive, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, Second Edition offers physicians, cardiologists, emergency room doctors, and basic scientists a complete and authoritative review of the state-of-the-art in glycoprotein IIb/IIIa receptor inhibitor use today.


Stent cardiology cardiovascular emergency heart disease myocardial infarction pharmacology platelet vascular disease

Editors and affiliations

  • A. Michael Lincoff
    • 1
  1. 1.Department of Cardiovascular MedicineThe Cleveland Clinic FoundationClevelandUSA

Bibliographic information